Skip to main content
Adil Sheikh, MD, Pulmonology, Boston, MA

AdilSheikhMD

Pulmonology Boston, MA

Critical Care Medicine, Lung Transplantation Medicine

Physician

Dr. Sheikh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sheikh's full profile

Already have an account?

  • Office

    15 Francis St
    Boston, MA 02115
    Phone+1 617-732-6770
    Fax+1 617-582-6102

Summary

  • Dr. Adil Sheikh is a transplant pulmonologist in Boston, MA and is affiliated with Brigham and Women's Hospital and Harvard Medical School. He specializes in lung transplantation medicine, critical care medicine with an interest in extracorporeal life support.

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2017 - 2020
  • Indiana University School of Medicine
    Indiana University School of MedicineResidency, Internal Medicine, 2014 - 2017
  • Aga Khan Medical College
    Aga Khan Medical CollegeClass of 2012
  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Lung Transplant and ECMO

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2023 - 2026
  • IN State Medical License
    IN State Medical License 2020 - 2023
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Press Mentions

  • COVID: Indianapolis Imams, Muslim Doctors Address Vaccine Concerns
    COVID: Indianapolis Imams, Muslim Doctors Address Vaccine ConcernsMarch 24th, 2021